Skip to main content

Peer Review reports

From: Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review

Original Submission
23 Jul 2019 Submitted Original manuscript
21 Apr 2020 Author responded Author comments - Ulf Helwig
23 Oct 2019 Reviewed Reviewer Report - Carlos Taxonera
24 Feb 2020 Reviewed Reviewer Report - Research Square Reviewer 1
Resubmission - Version 2
21 Apr 2020 Submitted Manuscript version 2
28 May 2020 Author responded Author comments - Ulf Helwig
27 Apr 2020 Reviewed Reviewer Report - Research Square Reviewer 1
Resubmission - Version 3
28 May 2020 Submitted Manuscript version 3
2 Jun 2020 Author responded Author comments - Ulf Helwig
Resubmission - Version 4
2 Jun 2020 Submitted Manuscript version 4
Publishing
3 Jun 2020 Editorially accepted
8 Jul 2020 Article published 10.1186/s12876-020-01332-w

You can find further information about peer review here.

Back to article page